Pancoast tumor echocardiography or ultrasound

Pancoast tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancoast tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancoast tumor echocardiography or ultrasound On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancoast tumor echocardiography or ultrasound All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancoast tumor echocardiography or ultrasound
CDC onPancoast tumor echocardiography or ultrasound
Pancoast tumor echocardiography or ultrasound in the news
Blogs on Pancoast tumor echocardiography or ultrasound
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Pancoast tumor echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overveiw

Pancoast tumor, a subtype of lung cancer located at the lung apex. On endobronchial and endoscopic ultrasound, characteristic findings of lung cancer may include: enlarged lymph nodes and local invasion to adjacent bronchial structures and mediastinum. Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.

Ultrasound

• Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.
• Common features of endobronchial ultrasound, include:

• Evaluation of lymph nodes and other structures in the mediastinum
• Mediastinum invasion staging
• Determination of management strategy
• Real time evaluation of structures
• Sensitivity 90% and specificity of 97%

• On ultrasound (endobronchial ultrasound), findings of Pancoast tumor may include:

• Enlarged lymph nodes
• Local invasion to adjacent bronchial structures and mediastinum

• The table below summarizes the advantages and disadvantages of both ultrasound modalities, for the diagnostic assessment of non-small cell lung cancer.

Procedure	Advantages	Disadvantages
Endobronchial ultrasound (EBUS)	Direct visualization of lymph node stations. Complements endoscopic ultrasound: covers lymph node stations 2R and 4R which are difficult to access by endoscopic ultrasound Lower false-negative rate than with blind transbronchial fine needle aspiration and fewer complications	More invasive than endoscopic ultrasound, few practitioners, but rapidly growing in popularity
Endoscopic ultrasound (EUS)	Least invasive modality Uses the esophagus to access mediastinal lymph nodes Excellent for staging lymph nodes Useful for station 2L and 4L, L adrenal, celiac lymph node	Cannot reliably access right sided paratracheal lymph node stations 2 R and 4R Accurate discrimination of primary hilar tumors and involved lymph nodes is important

• 

  Doppler endoscopic ultrasound: mediastinal lymph node

• 

  Endoscopic ultrasound: A biopsy window is found and an fine needle aspiration advanced into the mass

• 

  Endoscopic ultrasound: A lung mass which is partially behind the aorta is seen with endoscopic ultrasound